drug

Neuropsychological evaluation

neuropsychological evaluation
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by CHU de Reims
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

2
Visual Exploration and Attention: Studies in Patients With Schizophrenia and Autism Spectrum Disorders
NCT00914030—Unknown
Emotions in Schizophrenia and Bipolar Disorders: a Common Vulnerability?
NCT02805088—Unknown

KOLs & investigators

1
Anne GIERSCH, MD, PhDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
CHU de Reims
company
trial
Visual Exploration and Attention: Studies in Patients With Schizophrenia and Autism Spectrum Disorders
trial
Emotions in Schizophrenia and Bipolar Disorders: a Common Vulnerability?
NA
trial
indication
Schizophrenia
indication
Autism Spectrum Disorder
indication
Bipolar Disorder
indication
Schizophrenia
indication
KOL
Anne GIERSCH, MD, PhD
KOL score 5
person